Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89,500 JPY | -1.32% | -3.24% | -12.17% |
Business Summary
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rent
82.4
%
| 66,961 | 82.0 % | 68,162 | 82.4 % | +1.79% |
Real Estate
18.0
%
| 30,575 | 37.4 % | 14,903 | 18.0 % | -51.26% |
Real Estate Cost
-13.6
%
| -26,009 | -31.8 % | -11,214 | -13.6 % | -56.88% |
Other Rental
7.1
%
| 6,031 | 7.4 % | 5,878 | 7.1 % | -2.54% |
Received Water and Utility Bills
5.6
%
| 3,824 | 4.7 % | 4,655 | 5.6 % | +21.73% |
Dividend
0.8
%
| 528 | 0.6 % | 672 | 0.8 % | +27.19% |
Other Sales Costs
-0.4
%
| -201 | -0.2 % | -318 | -0.4 % | +58.06% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 81,710 | 100.0 % | 82,738 | 100.0 % | +1.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
66 | - | ||
61 | - | ||
Masahiko Nishida
BRD | Director/Board Member | 51 | 09-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Masahiko Nishida
BRD | Director/Board Member | 51 | 09-12-31 |
Osamu Ito
BRD | Director/Board Member | 61 | 21-11-24 |
Yoko Shirasu
BRD | Director/Board Member | - | Oct. 31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,978,509 | 6,542,719 ( 93.76 %) | 0 | 93.76 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
4,674 | 0.07% | 2,833,537 $ |
Company contact information
Japan Metropolitan Fund Investment Corp.
Tokyo Building, 21/F 2-7-3 Marunouchi
100-6420, Tokyo
+81 3 5293 7080
http://www.jmf-reit.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.17% | 4.06B | |
-7.14% | 47.25B | |
-9.69% | 20.36B | |
+2.10% | 16.01B | |
+18.62% | 12.15B | |
-2.91% | 9.95B | |
-12.54% | 8.68B | |
-1.98% | 8.46B | |
+8.10% | 8.39B | |
-0.41% | 5.95B |
- Stock Market
- Equities
- 8953 Stock
- Company Japan Metropolitan Fund Investment Corporation